The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 28, 2023

Filed:

Dec. 04, 2020
Applicant:

Ashvattha Therapeutics, Inc., Redwood City, CA (US);

Inventors:

Jeffrey Cleland, Redwood City, CA (US);

Rishi Sharma, Redwood City, CA (US);

Santiago Appiani, Redwood City, CA (US);

Assignee:

Ashvattha Therapeutics, Inc., Redwood City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/59 (2017.01); A61P 27/02 (2006.01); A61K 31/404 (2006.01); A61K 49/00 (2006.01); C08G 73/02 (2006.01);
U.S. Cl.
CPC ...
A61K 47/595 (2017.08); A61K 31/404 (2013.01); A61K 49/0034 (2013.01); A61K 49/0054 (2013.01); A61P 27/02 (2018.01); C08G 73/028 (2013.01);
Abstract

Dendrimer compositions and methods for the treatment of one or more inflammatory and/or angiogenic diseases and/or disorders of the eye include hydroxyl-terminated dendrimers complexed or conjugated with one or more active agents for the treatment or alleviation of one or more symptoms of the diseases of the eye, and/or for diagnosing the diseases and/or disorders of the eye. The dendrimers may include one or more ethylene diamine-core poly(amidoamine) (PAMAM) hydroxyl-terminated generation-4, 5, 6, 7, 8, 9, or 10 dendrimers. The active agents may be VEGFR tyrosine kinase inhibitors including sunitinib or analogues thereof. Preferably, the compositions are suitable for administration via a systemic route to target activated microglia/macrophages in retina/choroid.


Find Patent Forward Citations

Cleland, Jeffrey. (2023). Dendrimer compositions and methods for drug delivery to the eye (U.S. Patent No. 11612660). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11612660

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…